These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6310765)

  • 21. [Captopril in the treatment of severe circulatory insufficiency resistant to digitalis preparations and diuretics].
    Wiernikowski A; Michajlik A; Wysznacka-Aleksandrow W
    Pol Tyg Lek; 1984 Dec; 39(50):1657-9. PubMed ID: 6396593
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative study of three oral nitrate derivatives. A hemodynamic assessment in 10 patients with chronic heart failure (author's transl)].
    Bory M; Clavier P; Arnoux F; Djiane P; Egre A; Serradimigni A
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2437-42. PubMed ID: 6775296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
    Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
    J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of combination therapy of pentalong (PETN) with obsidan (propranolol) in patients with coronary insufficiency].
    Gruber G; Hambsch K
    Z Arztl Fortbild (Jena); 1977 Feb; 71(4):167-71. PubMed ID: 868090
    [No Abstract]   [Full Text] [Related]  

  • 25. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for acute renal insufficiency induced by diuretics in patients with congestive heart failure.
    Sun WY; Reiser IW; Chou SY
    Am J Kidney Dis; 2006 May; 47(5):798-808. PubMed ID: 16632018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Coronary therapy in geriatrics].
    Grübl M; Klein K; Siedek H
    Wien Med Wochenschr; 1973 Dec; 123(50):741-5. PubMed ID: 4763134
    [No Abstract]   [Full Text] [Related]  

  • 28. [Nicotinic acid in the treatment of chronic circulatory failure in patients with ischemic heart disease].
    Kats GL; Zhivotovskaia IA; Gnilitskaia VB; Alifanova RE; Mal'tseva NV
    Vrach Delo; 1989 Sep; (9):16-9. PubMed ID: 2609611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of vasodilator agents on the effectiveness of the complex treatment of patients with ischemic heart disease and congestive heart failure].
    Nemirovskaia MA; Zharov EI; Vertkin AL
    Kardiologiia; 1989 Apr; 29(4):37-40. PubMed ID: 2666705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy and prevention of ischemic heart diseases].
    Gill E
    Z Allgemeinmed; 1973 Oct; 49(28):1354-6. PubMed ID: 4756675
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
    Warembourg H; Théry C
    Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of cardiac and coronary insufficiency with Digi-Baxacor].
    Vorberg G
    Ther Ggw; 1974 Jun; 113(6):1008-16. PubMed ID: 4849984
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of coronary heart disease using Cormelian-Digotab: influence of the duration of therapy. 2. Field study by 107 physicians].
    Pollter J; Schnitker J
    Med Welt; 1976 Oct; 27(43):2074-9. PubMed ID: 792623
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experiences with a crataegus pentaerythrityl-tetranitrate combination drug in heart diseases due to coronary sclerosis in old age].
    Beier A; Königstein RP; Samec V
    Wien Med Wochenschr; 1974 Jun; 124(24):378-81. PubMed ID: 4858128
    [No Abstract]   [Full Text] [Related]  

  • 35. [Coronary disease. Therapeutic results in 2,841 ambulatory patients].
    Deibert K; Ihm P
    ZFA (Stuttgart); 1979 May; 55(14):902-8. PubMed ID: 452663
    [No Abstract]   [Full Text] [Related]  

  • 36. Study of a timed-release preparation of pentaerythritol tetranitrate.
    Siegel MB
    West Med Med J West; 1966 Aug; 7(8):218-21. PubMed ID: 5341140
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of coronary insufficiency. Clinical evaluation of a vasodilator agent and tranquilizer drug combination (Ro 4-6486)].
    Buzzi A
    Med Panam; 1963 Aug; 21(4):97-9. PubMed ID: 5900011
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of 70 cases of coronaropathy by a nitrogen derivative of prolonged action].
    Jouve A; Gerard R; Delaage M; Arnoux M
    Mars Med; 1967; 104(7):701-3. PubMed ID: 5609434
    [No Abstract]   [Full Text] [Related]  

  • 39. CHEMOTHERAPY OF CORONARY ARTERY DISEASE: A DOUBLE-BLIND CROSSOVER STUDY OF PETN AND PENTRIUM.
    TALBOT FJ
    Med Ann Dist Columbia; 1965 Jan; 34():19-22. PubMed ID: 14281449
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical evaluation of "pentrium", drug improving coronary circulation].
    Wasyluk J; Ruźyllo E
    Pol Tyg Lek; 1966 Nov; 21(48):1853-4. PubMed ID: 5979531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.